2014 Report of the ASHP Treasurer. A growing and forward-looking organization.

Am J Health Syst Pharm

Philip J. Schneider, B.S., Pharm.D., Treasurer, Olathe Medical Center, 20333 W. 151st Street, Olathe, KS 66061.

Published: August 2014

Download full-text PDF

Source
http://dx.doi.org/10.2146/sp140007DOI Listing

Publication Analysis

Top Keywords

2014 report
4
report ashp
4
ashp treasurer
4
treasurer growing
4
growing forward-looking
4
forward-looking organization
4
0
1
ashp
1
treasurer
1
growing
1

Similar Publications

Background: Comorbidity indices are used to help to estimate patients' length of hospital stay, care costs, outcomes, and mortality. Increasingly, they are considered in reimbursement models. The applicability of comorbidity indices to patients undergoing orthopaedic oncology surgery has not been studied.

View Article and Find Full Text PDF

The aim of this study was to determine whether the effects of extreme but discrete PM2.5 exposure from a coal mine fire on respiratory symptoms abated, persisted, or worsened over time, and whether they were exacerbated by COVID-19. We analysed longitudinal survey data from a cohort residing near a 2014 coalmine fire in regional Australia.

View Article and Find Full Text PDF

Population-based age-period-cohort analysis of declining Human Papillomavirus prevalence.

J Infect Dis

January 2025

Center for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Background: Most countries in the world have launched human papillomavirus (HPV) vaccination programmes and declining prevalences of HPV are reported. We aimed to disentangle the influences of calendar time, birth cohort and age by analysing HPV prevalences in the population-based cervical screening programme using age-period-cohort modelling.

Methods: All 836,314 primary HPV-based cervical screening tests from women aged 23-64 between 2014-2023 in the capital region of Sweden were identified in the Swedish National Cervical Screening Registry.

View Article and Find Full Text PDF

Analysis of Research Waste in Phase III/IV Randomized Controlled Trials of Botulinum Toxin Type A.

Dermatol Surg

January 2025

All authors are affiliated with the Department of Plastic & Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Ninth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Background: The application of randomized controlled trials (RCTs) outcomes of botulinum toxin type A (BoNT-A) to actual patient care faces a significant hurdle due to research waste (RW). This includes the results of RCTs that have not been published even 4 years after completion and those with insufficiently reported outcomes and design flaws. The prevalence of RW within BoNT-A-associated RCTs remains uncertain.

View Article and Find Full Text PDF

Background: Anthelmintic resistance (AR) threatens effective equine parasite control. Quarterly data summaries from faecal worm egg count testing (FWECT) performed by UK laboratories have appeared in Equine Quarterly Disease Surveillance Reports (EQDSR) since 2007, but have not previously been assessed.

Objectives: To assess strongyle FWECT methods and thresholds used by UK laboratories.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!